Nanoparticles for CRISPR-Cas9 delivery.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30147994.
- Also identified by DOI 10.1038/s41551-017-0158-x and PMC identifier 6107070.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The DNA mutation that causes Duchenne muscular dystrophy in mice can be corrected, with minimal off-target effects, by gold nanoparticles carrying the CRISPR components.